The strongest evidence implicating G6PD deficiency in malaria protection would ideally be consistent with an additive genetic model, with hemizygous males and homozygous females exhibiting similar clinical phenotypes, and heterozygous females displaying intermediate phenotypes. Here, G6PD is linked to malaria.